CNAM
Campbell Newman Asset Management Portfolio holdings
AUM
$1.26B
This Quarter Return
+12.54%
1 Year Return
+22.71%
3 Year Return
+86.74%
5 Year Return
+151.94%
10 Year Return
+399.95%
AUM
$1.16B
AUM Growth
+$1.16B
(+9.6%)
Cap. Flow
-$21.3M
Cap. Flow
% of AUM
-1.84%
Top 10 Holdings %
Top 10 Hldgs %
42.61%
Holding
112
New
2
Increased
31
Reduced
61
Closed
2
Top Buys
| 1 |
Arthur J. Gallagher & Co
AJG
|
$4.48M |
| 2 |
Matador Resources
MTDR
|
$1.09M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$342K |
| 4 |
UnitedHealth
UNH
|
$178K |
| 5 |
Medpace
MEDP
|
$14.1K |
Top Sells
| 1 |
Crown Castle
CCI
|
$4.6M |
| 2 |
Broadcom
AVGO
|
$2.29M |
| 3 |
EOG Resources
EOG
|
$1.45M |
| 4 |
Microsoft
MSFT
|
$1.37M |
| 5 |
Apple
AAPL
|
$990K |
Sector Composition
| 1 | Technology | 37.61% |
| 2 | Healthcare | 16.14% |
| 3 | Financials | 13.34% |
| 4 | Consumer Discretionary | 8.98% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Ciena
CIEN
$13.4B
| $1.44M | 0.12% |
32,006
-188
| -0.6% | -$8.46K |
|
77
Walt Disney
DIS
$211B
| $1.41M | 0.12% |
15,565
-2,000
| -11% | -$181K |
|
78
Starbucks
SBUX
$99.2B
| $1.41M | 0.12% |
14,637
-342
| -2% | -$32.8K |
|
79
AbbVie
ABBV
$374B
| $1.4M | 0.12% |
9,026
| – | – |
|
80
Advanced Micro Devices
AMD
$263B
| $1.34M | 0.12% |
9,080
+39
| +0.4% | +$5.75K |
|
81
Halozyme
HALO
$8.75B
| $1.24M | 0.11% |
33,554
-507
| -1% | -$18.7K |
|
82
Supernus Pharmaceuticals
SUPN
$2.52B
| $1.23M | 0.11% |
42,381
+26
| +0.1% | +$752 |
|
83
Pacira BioSciences
PCRX
$1.22B
| $1.15M | 0.1% |
34,063
-522
| -2% | -$17.6K |
|
84
Blackbaud
BLKB
$3.23B
| $1.14M | 0.1% |
13,190
+54
| +0.4% | +$4.68K |
|
|
PRFT
85
DELISTED
Perficient Inc
PRFT
| $1.13M | 0.1% |
17,234
-176
| -1% | -$11.6K |
|
|
86
Matador Resources
MTDR
$6.09B
| $1.09M | 0.09% |
+19,214
| New | +$1.09M |
|
87
MP Materials
MP
$11.7B
| $1.02M | 0.09% |
51,635
-792
| -2% | -$15.7K |
|
88
iShares Russell Mid-Cap ETF
IWR
$44B
| $998K | 0.09% |
12,840
| – | – |
|
89
MarketAxess Holdings
MKTX
$6.78B
| $959K | 0.08% |
3,275
-20
| -0.6% | -$5.86K |
|
90
Bristol-Myers Squibb
BMY
$96.7B
| $921K | 0.08% |
17,957
-14,869
| -45% | -$763K |
|
91
lululemon athletica
LULU
$23.8B
| $902K | 0.08% |
1,764
+9
| +0.5% | +$4.6K |
|
92
Moelis & Co
MC
$5.21B
| $888K | 0.08% |
15,827
+84
| +0.5% | +$4.72K |
|
93
T-Mobile US
TMUS
$284B
| $847K | 0.07% |
5,284
-71
| -1% | -$11.4K |
|
94
CEVA Inc
CEVA
$520M
| $749K | 0.06% |
32,968
-505
| -2% | -$11.5K |
|
95
Vertex Pharmaceuticals
VRTX
$102B
| $725K | 0.06% |
1,782
-25
| -1% | -$10.2K |
|
96
Verint Systems
VRNT
$1.23B
| $703K | 0.06% |
25,999
-281
| -1% | -$7.6K |
|
97
Boeing
BA
$176B
| $640K | 0.06% |
2,455
+18
| +0.7% | +$4.69K |
|
98
Pfizer
PFE
$141B
| $615K | 0.05% |
21,371
| – | – |
|
99
Integra LifeSciences
IART
$1.18B
| $612K | 0.05% |
14,061
-208
| -1% | -$9.06K |
|
100
Procter & Gamble
PG
$370B
| $608K | 0.05% |
4,150
| – | – |
|